1-2 of 2
Beatrix Ueberheide
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Melanoma-Secreted Amyloid Beta Suppresses Neuroinflammation and Promotes Brain Metastasis

Available to Purchase
Kevin Kleffman, Grace Levinson, Indigo V.L. Rose, Lili M. Blumenberg, Sorin A.A. Shadaloey, Avantika Dhabaria, Eitan Wong, Francisco Galán-Echevarría, Alcida Karz, Diana Argibay, Richard Von Itter, Alfredo Floristán, Gillian Baptiste, Nicole M. Eskow, James A. Tranos, Jenny Chen, Eleazar C. Vega y Saenz de Miera, Melissa Call, Robert Rogers, George Jour, Youssef Zaim Wadghiri, Iman Osman, Yue-Ming Li, Paul Mathews, Ronald B. DeMattos, Beatrix Ueberheide, Kelly V. Ruggles, Shane A. Liddelow, Robert J. Schneider, Eva Hernando
Journal: Cancer Discovery
Cancer Discov (2022) 12 (5): 1314–1335.
https://doi.org/10.1158/2159-8290.CD-21-1006
Published: 02 May 2022
View articletitled, Melanoma-Secreted Amyloid Beta Suppresses Neuroinflammation and Promotes Brain Metastasis
Open the PDF for Melanoma-Secreted Amyloid Beta Suppresses Neuroinflammation and Promotes Brain Metastasis in another window
Includes: Multimedia, Supplementary data
Journal Articles

Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast Cancer

Available to Purchase
Chewei Anderson Chang, Jayu Jen, Shaowen Jiang, Azin Sayad, Arvind Singh Mer, Kevin R. Brown, Allison M.L. Nixon, Avantika Dhabaria, Kwan Ho Tang, David Venet, Christos Sotiriou, Jiehui Deng, Kwok-kin Wong, Sylvia Adams, Peter Meyn, Adriana Heguy, Jane A. Skok, Aristotelis Tsirigos, Beatrix Ueberheide, Jason Moffat, Abhyudai Singh, Benjamin Haibe-Kains, Alireza Khodadadi-Jamayran, Benjamin G. Neel
Journal: Cancer Discovery
Cancer Discov (2022) 12 (4): 1022–1045.
https://doi.org/10.1158/2159-8290.CD-20-1265
Published: 01 April 2022
View articletitled, Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast Cancer
Open the PDF for Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast Cancer in another window
Includes: Supplementary data